I’ve been reviewing data on biopharma business trends for 16 years now, and no one does the number crunching better than Chris Dokomajilar at DealForma. I’ve seen the data pressure tested repeatedly, and it is solid. We’re proud to have him contribute regular pieces to Endpoints News.

DealForma is one of the most valuable tools for business leaders in biotech, whether you are focused on partnering or fundraising (equity, VC investments). Chris and team are nimble, responsive and thorough and with their help, we have been well-equipped with data to support terms and contract negotiations.

Best product in the business!

DealForma is an exceptional and intuitive platform with reliable data that has saved us countless hours. The support team is quick to respond, and they go above and beyond to make sure we get what we need whether it is a quick question or a more intensive project.

I like DealForma’s comprehensive coverage of the life sciences industry. The intuitive search functions allow me to quickly extract deal benchmarks and other insights, which are useful in helping me evaluate potential opportunities.

The breadth and quality of information in DealForma has saved our team countless hours over other data sources. The focus on customers also sets them apart. Whether it’s a quick question or a custom project, we get the right people to talk to fast.